UMB's lawsuit claimed Bristol Myers Squibb slow-rolled FDA applications to avoid $6.4 billion in payments. A judge dropped the case on a technicality, but UMB vows to press on.Court dismisses lawsuit against Bristol Myers, but UMB says the fight is not over
UMB's lawsuit claimed Bristol Myers Squibb slow-rolled FDA applications to avoid $6.4 billion in payments. A judge dropped the case on a technicality, but UMB vows to press on.